Welcome
Support Centre
12 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
The prevalence and associations of fatigue in Systemic Lupus Erythematosus (SLE) and the effects of aerobic exercise on fatigue and sleep patterns in SLE
Source of recordUK Trials
ISRCTNISRCTN71091471
Date ISRCTN assigned18/07/2002
Local reference number(s)T0519
Public titleThe prevalence and associations of fatigue in Systemic Lupus Erythematosus (SLE) and the effects of aerobic exercise on fatigue and sleep patterns in SLE
Scientific title
AcronymN/A
Disease/condition/study domainSystemic lupus erythematosus (SLE)
Study hypothesisTo test the efficacy of a graded aerobic exercise programme in treating fatigue in systemic lupus erythematosus.
Design/methodologyRandomised controlled trial
Research ethics reviewEthical approval was obtained from the district research ethics committee and all subjects gave valid and informed consent before entering the study.
Countries of trialUnited Kingdom
Participants - inclusion criteriaFemale patients fulfilling American College of Rheumatology (ACR) classification for SLE
Participants - exclusion criteria1. Evidence of active severe myositis, nephritis, neurological involvement or cardiac or pulmonary disease
2. Pregnant patients
3. Patients under 16 or over 55 years
Patient information material
Anticipated start date01/01/2001
Anticipated end date01/01/2003
Status of trialCompleted
Target number of participants93
InterventionsAllocation using a minimisation protocol to 12 weeks of either graded exercise therapy, relaxation therapy or no intervention
Primary outcome measure(s)Self-rated clinical global impression change score, measured at baseline and three months.
Secondary outcome measure(s)1. Assessments of symptoms, measured at baseline and three months
2. Functional capacity, measured at baseline and three months
3. Fitness, measured at baseline and three months
PublicationsResults in http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12730519
Sources of fundingArthritis Research Campaign (UK)
Sponsor nameArthritis Research Campaign (UK)
Sponsor detailsCopeman House
St Mary's Court
St Mary's Gate
Chesterfield
Derbyshire
United Kingdom
S41 7TD
Sponsor emailinfo@arc.org.uk
Sponsor websitehttp://www.arc.org.uk
Contact nameDr David D'Cruz
Contact detailsThe Lupus Research Unit
The Rayne Institute
St Thomas' Hospital
Lambeth Palace Road
London
United Kingdom
SE1 7EH
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN71091471
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central